Treatment of Migraines Potentially Related to Cosmetic PDGF Under-Eye Injections
For migraines of any etiology, including those potentially triggered by cosmetic procedures, sumatriptan is an appropriate and effective second-line treatment when NSAIDs fail, and should be used according to standard migraine protocols. 1
Understanding the Clinical Context
The question implies migraines potentially triggered by cosmetic PDGF injections under the eye. While this is an unusual trigger, the treatment approach follows standard migraine management principles, as the pathophysiology of the migraine attack itself remains the same regardless of trigger. 1
Acute Treatment Algorithm
First-Line Treatment: NSAIDs
- Start with NSAIDs as first-line therapy: ibuprofen 400-800mg, naproxen sodium 500-825mg, or aspirin 650-1000mg 1, 2
- Acetaminophen alone is ineffective for migraine 1
- NSAIDs should be administered as early as possible during the attack for optimal efficacy 1
Second-Line Treatment: Sumatriptan
When NSAIDs provide inadequate relief, sumatriptan is the appropriate next step 1, 2
Dosing recommendations:
- Oral sumatriptan: 50mg or 100mg (the 100mg dose may not provide greater effect than 50mg but has higher adverse event rates) 3, 4
- If headache persists or returns after 2 hours, a second dose may be taken with at least 2 hours between doses 3
- Maximum daily dose: 200mg in 24 hours 3
- Subcutaneous sumatriptan 6mg provides highest efficacy (59% pain-free at 2 hours) and can be effective regardless of timing during the attack 1, 5
Adjunctive Antiemetic Therapy
Add an antiemetic even if vomiting is not present—nausea itself warrants treatment 2
- Metoclopramide 10mg IV or orally, given 20-30 minutes before or with analgesics, provides synergistic analgesia beyond treating nausea 2
- Prochlorperazine 10mg IV or 25mg orally/suppository is equally effective 2
Critical Contraindications to Sumatriptan
Do not use sumatriptan if the patient has: 3
- Uncontrolled hypertension
- Heart disease or risk factors for heart disease (unless cardiac evaluation shows no problem)
- Basilar or hemiplegic migraine
- Peripheral vascular disease
- History of stroke or TIAs
- Severe liver problems (if mild-moderate hepatic impairment, maximum dose 50mg) 3
Drug interactions to avoid: 3
- Do not use within 24 hours of other triptans or ergotamine derivatives
- Use caution with SSRIs, SNRIs, TCAs, or MAOIs due to serotonin syndrome risk 3, 6
Preventing Medication Overuse Headache
This is a critical pitfall that creates a vicious cycle of worsening headaches: 1, 2
- Limit acute treatment to no more than 2 days per week 1, 2
- Triptans: maximum 10 days per month 1
- NSAIDs: maximum 15 days per month 1
- Never use opioids or butalbital-containing compounds—these cause dependency, rebound headaches, and eventual loss of efficacy 1, 7
When to Consider Preventive Therapy
Initiate preventive therapy if: 1, 2
- Two or more migraine attacks per month causing disability for 3+ days
- Using acute medications more than twice weekly
- Acute treatments fail or are contraindicated
- Uncommon migraine conditions present (prolonged aura, hemiplegic migraine)
First-line preventive agents: 1
- Propranolol 80-240mg daily
- Timolol 20-30mg daily
- Amitriptyline 30-150mg daily
- Divalproex sodium 500-1500mg daily
Special Considerations for Cosmetic Procedure-Related Triggers
If the PDGF injection is indeed triggering migraines:
- Identify and avoid the trigger (consider discontinuing or avoiding future PDGF treatments) 1
- Document the temporal relationship between the cosmetic procedure and migraine onset
- Consider whether this represents a new-onset headache pattern that might warrant neuroimaging to rule out secondary causes, particularly given the periorbital location of the injection 1
Lifestyle Modifications
Implement these alongside pharmacotherapy: 1
- Maintain adequate hydration and regular meals
- Ensure consistent, sufficient sleep patterns
- Limit caffeine intake
- Regular exercise program
- Stress management techniques (yoga, cognitive-behavioral therapy, mindfulness) 1
The treatment approach for this migraine is identical to standard migraine management—the potential cosmetic trigger does not change the acute treatment algorithm, though identifying and avoiding the trigger is essential for long-term management. 1